PTC Therapeutics, Inc.

NASDAQ:PTCT

53.61 (USD) • At close March 12, 2025
Bedrijfsnaam PTC Therapeutics, Inc.
Symbool PTCT
Munteenheid USD
Prijs 53.61
Beurswaarde 4,228,188,534
Dividendpercentage 0%
52-weken bereik 23.995 - 55.6
Industrie Biotechnology
Sector Healthcare
CEO Dr. Matthew B. Klein F.A.C.S., FACS, M.D., M.S., MS
Website https://www.ptcbio.com

An error occurred while fetching data.

Over PTC Therapeutics, Inc.

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple

Vergelijkbare Aandelen

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

27.42 USD

Tilray Brands, Inc. logo

Tilray Brands, Inc.

TLRY

0.64 USD

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

9.03 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

55 USD

EQRx, Inc. logo

EQRx, Inc.

EQRX

2.34 USD

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

IOVA

3.82 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.35 USD

Insmed Incorporated logo

Insmed Incorporated

INSM

74.04 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

1.01 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

1.12 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)